Sucampo Pharma (SCMP) Tops Q2 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Sucampo Reports Second Quarter 2016 Financial Results
August 3, 2016 6:30 AM EDTResults Driven by 49% Growth in Revenue
Adjusted EPS Growth of 10%
Company Reiterates 2016 Guidance
Company to Host Conference Call Today at 8:30 a.m. ET
ROCKVILLE, Md., Aug. 03, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ: SCMP), a global biopharmaceutical company, today reported consolidated financial results for the second quarter ended June 30, 2016.
... More